Catalyst Funds Management Pty »

Black Diamond Therapeutics shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2025-09-30 $105k 28k 3.79
2025-06-30 $46k 19k 2.48

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
NVIDIA Corp Ordinary Shares (NVDA)
Meta Platforms Ordinary Shares - Class A (META)
Microsoft Corp Ordinary Shares (MSFT)
Xtrackers Hvst CSI 300 China A-Shs ETF Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR)
Rio Tinto Adr (RIO)
News Corp Ordinary Shares - Class B (NWS)
Revolution Medicines Ordinary Shares (RVMD)
Amphenol Corp Ordinary Shares - Class A (APH)
Broadcom Ordinary Shares (AVGO)
CRH Ordinary Shares (CRH)
Alphabet Ordinary Shares - Class C (GOOG)
Paramount Skydance Corp Ordinary Shares - Class B (PSKY)
JPMorgan Chase & Co Ordinary Shares (JPM)
Alphabet Ordinary Shares - Class A (GOOGL)

View all positions for Catalyst Funds Management Pty

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
Vestal Point Capital
NEA Management Company
Vanguard Group
Tang Capital Management
Marshall Wace
Siren
BlackRock
Arrowstreet Capital, Limited Partnership
Millennium Management
UBS Group
AWM Investment Company
Renaissance Technologies
Geode Capital Management
Northern Trust

View all funds holding Black Diamond Therapeutics